CTH and chronic myelogenous leukemia, BCR-ABL1 positive: The results showed that the CBS mRNA level was significantly increased in CML patients by 2.13 ± 0.34 fold compared with the control groups (P = 0.0033), while the levels of CSE and 3-MST had no significant differences between the two groups (Fig. 1a).